Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Adl 8-2698
2. Adl8-2698
3. Alvimopan
4. Alvimopan Anhydrous
5. Anhydrous Alvimopan
6. Ly 246736
7. Ly-246736
8. Ly246736
9. Trans-3,4-dimethyl-4-(3-hydroxyphenyl) Piperidine
1. Alvimopan Dihydrate
2. 170098-38-1
3. Alvimopan Hydrate
4. Alvimopan (dihydrate)
5. Ly 246736 Dihydrate
6. Alvimopan [usan]
7. Ly-246736 Dihydrate
8. 677c126aet
9. Alvimopan (usan)
10. Adl-8-2698
11. 2-[[(2s)-2-benzyl-3-[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperi Dyl]propanoyl]amino]acetic Acid Dihydrate
12. 2-[[(2s)-2-benzyl-3-[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic Acid;dihydrate
13. (((2s)-2-(((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoyl)amino)acetic Acid Dihydrate
14. 2-[[(2s)-2-benzyl-3-[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic Acid,dihydrate
15. Ly246736
16. Ly-246736
17. Entrareg
18. Alvimopan [usan:inn:ban]
19. Unii-677c126aet
20. Alvimopandihydrate
21. 156053-89-3 (anhydrous)
22. Entereg (tn)
23. Alvimopan [hsdb]
24. Alvimopan [vandf]
25. Alvimopan 2-hydrate
26. Schembl1477341
27. Alvimopan [orange Book]
28. Alvimopan Dihydrate [mi]
29. Dtxsid40168794
30. Hms3886i18
31. Alvimopan Dihydrate [mart.]
32. Bcp10120
33. Sb-767905
34. Hy-76657a
35. S5701
36. Akos015899533
37. Ac-8813
38. Am84590
39. Ccg-269339
40. Cs-1540
41. As-75035
42. Ba164152
43. Glycine, N-((2s)-2-(((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, Dihydrate
44. Glycine, N-(2-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, Dihydrate, (3r-(1(s*),3alpha,4alpha))-
45. Glycine, N-(2-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-,dihydrate, (3r-(1(s*),3-alpha,4-alpha))-
46. D02878
47. D70720
48. 098a381
49. A882054
50. (2s, 3r, 4r)[[2-[[4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl ]methyl]-1-oxo-3-phenylpropyl]-amino]acetic Acid Dihydrate
51. 2-((s)-2-benzyl-3-((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)acetic Acid Dihydrate
52. 2-[(2s)-2-{[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl}-3-phenylpropanamido]acetic Acid Dihydrate
53. 2-[(2s)-2-benzyl-3-[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanamido]acetic Acid Dihydrate
54. Glycine, N-(2-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, Dihydrate, (3r-(1(s*),3.alpha.,4.alpha.))-
| Molecular Weight | 460.6 g/mol |
|---|---|
| Molecular Formula | C25H36N2O6 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 8 |
| Exact Mass | 460.25733687 g/mol |
| Monoisotopic Mass | 460.25733687 g/mol |
| Topological Polar Surface Area | 91.9 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 606 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
ABOUT THIS PAGE
A 170098-38-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 170098-38-1, including repackagers and relabelers. The FDA regulates 170098-38-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 170098-38-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 170098-38-1 supplier is an individual or a company that provides 170098-38-1 active pharmaceutical ingredient (API) or 170098-38-1 finished formulations upon request. The 170098-38-1 suppliers may include 170098-38-1 API manufacturers, exporters, distributors and traders.
170098-38-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 170098-38-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 170098-38-1 GMP manufacturer or 170098-38-1 GMP API supplier for your needs.
A 170098-38-1 CoA (Certificate of Analysis) is a formal document that attests to 170098-38-1's compliance with 170098-38-1 specifications and serves as a tool for batch-level quality control.
170098-38-1 CoA mostly includes findings from lab analyses of a specific batch. For each 170098-38-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
170098-38-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (170098-38-1 EP), 170098-38-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (170098-38-1 USP).
LOOKING FOR A SUPPLIER?
